ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Atopic Dermatitis Medication Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-6T12992
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Atopic Dermatitis Medication Market Research Report 2022
BUY CHAPTERS

Global Atopic Dermatitis Medication Market Research Report 2025

Code: QYRE-Auto-6T12992
Report
February 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Viatris
Allergan plc
Novartis
Bayer
Teva Pharmaceuticals
Bausch Health
Astellas Pharma
Astrazeneca plc
Metrochem API
Arcutis Biotherapeutics
LEO Pharma
Pfizer Inc
Sanofi

Atopic Dermatitis Medication Market

The global market for Atopic Dermatitis Medication was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Atopic dermatitis is a chronic inflammatory skin condition characterized by dry, itchy, and inflamed skin. Treatment for atopic dermatitis aims to relieve symptoms, reduce inflammation, and prevent flare-ups. There are various types of medications available to manage atopic dermatitis, and the choice of treatment depends on the severity of the condition and the patient"s age.
North American market for Atopic Dermatitis Medication is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Atopic Dermatitis Medication is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Atopic Dermatitis Medication in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Atopic Dermatitis Medication include Pfizer, Viatris, Allergan, Leo Pharma, Sanofi, Novartis, Bayer, Teva Pharmaceuticals, Bausch Health, Astellas Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Atopic Dermatitis Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atopic Dermatitis Medication.
The Atopic Dermatitis Medication market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Atopic Dermatitis Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Atopic Dermatitis Medication companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Atopic Dermatitis Medication Market Report

Report Metric Details
Report Name Atopic Dermatitis Medication Market
Segment by Type
  • Corticosteroids
  • PDE4 Inhibitors
  • Biologics
  • Skin Barrier Emollients
  • CNI Immunosuppressants
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Drugstore
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Viatris, Allergan, Leo Pharma, Sanofi, Novartis, Bayer, Teva Pharmaceuticals, Bausch Health, Astellas Pharma, AstraZeneca, Metrochem API, Arcutis Biotherapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Atopic Dermatitis Medication company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Atopic Dermatitis Medication Market report?

Ans: The main players in the Atopic Dermatitis Medication Market are Pfizer, Viatris, Allergan, Leo Pharma, Sanofi, Novartis, Bayer, Teva Pharmaceuticals, Bausch Health, Astellas Pharma, AstraZeneca, Metrochem API, Arcutis Biotherapeutics

What are the Application segmentation covered in the Atopic Dermatitis Medication Market report?

Ans: The Applications covered in the Atopic Dermatitis Medication Market report are Hospital, Clinic, Drugstore, Others

What are the Type segmentation covered in the Atopic Dermatitis Medication Market report?

Ans: The Types covered in the Atopic Dermatitis Medication Market report are Corticosteroids, PDE4 Inhibitors, Biologics, Skin Barrier Emollients, CNI Immunosuppressants, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Atopic Dermatitis Medication Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Corticosteroids
1.2.3 PDE4 Inhibitors
1.2.4 Biologics
1.2.5 Skin Barrier Emollients
1.2.6 CNI Immunosuppressants
1.2.7 Others
1.3 Market by Application
1.3.1 Global Atopic Dermatitis Medication Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drugstore
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Atopic Dermatitis Medication Market Perspective (2020-2031)
2.2 Global Atopic Dermatitis Medication Growth Trends by Region
2.2.1 Global Atopic Dermatitis Medication Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Atopic Dermatitis Medication Historic Market Size by Region (2020-2025)
2.2.3 Atopic Dermatitis Medication Forecasted Market Size by Region (2026-2031)
2.3 Atopic Dermatitis Medication Market Dynamics
2.3.1 Atopic Dermatitis Medication Industry Trends
2.3.2 Atopic Dermatitis Medication Market Drivers
2.3.3 Atopic Dermatitis Medication Market Challenges
2.3.4 Atopic Dermatitis Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Atopic Dermatitis Medication Players by Revenue
3.1.1 Global Top Atopic Dermatitis Medication Players by Revenue (2020-2025)
3.1.2 Global Atopic Dermatitis Medication Revenue Market Share by Players (2020-2025)
3.2 Global Atopic Dermatitis Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Atopic Dermatitis Medication Revenue
3.4 Global Atopic Dermatitis Medication Market Concentration Ratio
3.4.1 Global Atopic Dermatitis Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Atopic Dermatitis Medication Revenue in 2024
3.5 Global Key Players of Atopic Dermatitis Medication Head office and Area Served
3.6 Global Key Players of Atopic Dermatitis Medication, Product and Application
3.7 Global Key Players of Atopic Dermatitis Medication, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Atopic Dermatitis Medication Breakdown Data by Type
4.1 Global Atopic Dermatitis Medication Historic Market Size by Type (2020-2025)
4.2 Global Atopic Dermatitis Medication Forecasted Market Size by Type (2026-2031)
5 Atopic Dermatitis Medication Breakdown Data by Application
5.1 Global Atopic Dermatitis Medication Historic Market Size by Application (2020-2025)
5.2 Global Atopic Dermatitis Medication Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Atopic Dermatitis Medication Market Size (2020-2031)
6.2 North America Atopic Dermatitis Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Atopic Dermatitis Medication Market Size by Country (2020-2025)
6.4 North America Atopic Dermatitis Medication Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Atopic Dermatitis Medication Market Size (2020-2031)
7.2 Europe Atopic Dermatitis Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Atopic Dermatitis Medication Market Size by Country (2020-2025)
7.4 Europe Atopic Dermatitis Medication Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Atopic Dermatitis Medication Market Size (2020-2031)
8.2 Asia-Pacific Atopic Dermatitis Medication Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Atopic Dermatitis Medication Market Size by Region (2020-2025)
8.4 Asia-Pacific Atopic Dermatitis Medication Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Atopic Dermatitis Medication Market Size (2020-2031)
9.2 Latin America Atopic Dermatitis Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Atopic Dermatitis Medication Market Size by Country (2020-2025)
9.4 Latin America Atopic Dermatitis Medication Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Atopic Dermatitis Medication Market Size (2020-2031)
10.2 Middle East & Africa Atopic Dermatitis Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Atopic Dermatitis Medication Market Size by Country (2020-2025)
10.4 Middle East & Africa Atopic Dermatitis Medication Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Atopic Dermatitis Medication Introduction
11.1.4 Pfizer Revenue in Atopic Dermatitis Medication Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Viatris
11.2.1 Viatris Company Details
11.2.2 Viatris Business Overview
11.2.3 Viatris Atopic Dermatitis Medication Introduction
11.2.4 Viatris Revenue in Atopic Dermatitis Medication Business (2020-2025)
11.2.5 Viatris Recent Development
11.3 Allergan
11.3.1 Allergan Company Details
11.3.2 Allergan Business Overview
11.3.3 Allergan Atopic Dermatitis Medication Introduction
11.3.4 Allergan Revenue in Atopic Dermatitis Medication Business (2020-2025)
11.3.5 Allergan Recent Development
11.4 Leo Pharma
11.4.1 Leo Pharma Company Details
11.4.2 Leo Pharma Business Overview
11.4.3 Leo Pharma Atopic Dermatitis Medication Introduction
11.4.4 Leo Pharma Revenue in Atopic Dermatitis Medication Business (2020-2025)
11.4.5 Leo Pharma Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Atopic Dermatitis Medication Introduction
11.5.4 Sanofi Revenue in Atopic Dermatitis Medication Business (2020-2025)
11.5.5 Sanofi Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Atopic Dermatitis Medication Introduction
11.6.4 Novartis Revenue in Atopic Dermatitis Medication Business (2020-2025)
11.6.5 Novartis Recent Development
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Atopic Dermatitis Medication Introduction
11.7.4 Bayer Revenue in Atopic Dermatitis Medication Business (2020-2025)
11.7.5 Bayer Recent Development
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Company Details
11.8.2 Teva Pharmaceuticals Business Overview
11.8.3 Teva Pharmaceuticals Atopic Dermatitis Medication Introduction
11.8.4 Teva Pharmaceuticals Revenue in Atopic Dermatitis Medication Business (2020-2025)
11.8.5 Teva Pharmaceuticals Recent Development
11.9 Bausch Health
11.9.1 Bausch Health Company Details
11.9.2 Bausch Health Business Overview
11.9.3 Bausch Health Atopic Dermatitis Medication Introduction
11.9.4 Bausch Health Revenue in Atopic Dermatitis Medication Business (2020-2025)
11.9.5 Bausch Health Recent Development
11.10 Astellas Pharma
11.10.1 Astellas Pharma Company Details
11.10.2 Astellas Pharma Business Overview
11.10.3 Astellas Pharma Atopic Dermatitis Medication Introduction
11.10.4 Astellas Pharma Revenue in Atopic Dermatitis Medication Business (2020-2025)
11.10.5 Astellas Pharma Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Atopic Dermatitis Medication Introduction
11.11.4 AstraZeneca Revenue in Atopic Dermatitis Medication Business (2020-2025)
11.11.5 AstraZeneca Recent Development
11.12 Metrochem API
11.12.1 Metrochem API Company Details
11.12.2 Metrochem API Business Overview
11.12.3 Metrochem API Atopic Dermatitis Medication Introduction
11.12.4 Metrochem API Revenue in Atopic Dermatitis Medication Business (2020-2025)
11.12.5 Metrochem API Recent Development
11.13 Arcutis Biotherapeutics
11.13.1 Arcutis Biotherapeutics Company Details
11.13.2 Arcutis Biotherapeutics Business Overview
11.13.3 Arcutis Biotherapeutics Atopic Dermatitis Medication Introduction
11.13.4 Arcutis Biotherapeutics Revenue in Atopic Dermatitis Medication Business (2020-2025)
11.13.5 Arcutis Biotherapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Viatris
Allergan plc
Novartis
Bayer
Teva Pharmaceuticals
Bausch Health
Astellas Pharma
Astrazeneca plc
Metrochem API
Arcutis Biotherapeutics
LEO Pharma
Pfizer Inc
Sanofi
List of Tables
 Table 1. Global Atopic Dermatitis Medication Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Corticosteroids
 Table 3. Key Players of PDE4 Inhibitors
 Table 4. Key Players of Biologics
 Table 5. Key Players of Skin Barrier Emollients
 Table 6. Key Players of CNI Immunosuppressants
 Table 7. Key Players of Others
 Table 8. Global Atopic Dermatitis Medication Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Atopic Dermatitis Medication Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Atopic Dermatitis Medication Market Size by Region (2020-2025) & (US$ Million)
 Table 11. Global Atopic Dermatitis Medication Market Share by Region (2020-2025)
 Table 12. Global Atopic Dermatitis Medication Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 13. Global Atopic Dermatitis Medication Market Share by Region (2026-2031)
 Table 14. Atopic Dermatitis Medication Market Trends
 Table 15. Atopic Dermatitis Medication Market Drivers
 Table 16. Atopic Dermatitis Medication Market Challenges
 Table 17. Atopic Dermatitis Medication Market Restraints
 Table 18. Global Atopic Dermatitis Medication Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Atopic Dermatitis Medication Market Share by Players (2020-2025)
 Table 20. Global Top Atopic Dermatitis Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atopic Dermatitis Medication as of 2024)
 Table 21. Ranking of Global Top Atopic Dermatitis Medication Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Atopic Dermatitis Medication Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Atopic Dermatitis Medication, Headquarters and Area Served
 Table 24. Global Key Players of Atopic Dermatitis Medication, Product and Application
 Table 25. Global Key Players of Atopic Dermatitis Medication, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Atopic Dermatitis Medication Market Size by Type (2020-2025) & (US$ Million)
 Table 28. Global Atopic Dermatitis Medication Revenue Market Share by Type (2020-2025)
 Table 29. Global Atopic Dermatitis Medication Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 30. Global Atopic Dermatitis Medication Revenue Market Share by Type (2026-2031)
 Table 31. Global Atopic Dermatitis Medication Market Size by Application (2020-2025) & (US$ Million)
 Table 32. Global Atopic Dermatitis Medication Revenue Market Share by Application (2020-2025)
 Table 33. Global Atopic Dermatitis Medication Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 34. Global Atopic Dermatitis Medication Revenue Market Share by Application (2026-2031)
 Table 35. North America Atopic Dermatitis Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. North America Atopic Dermatitis Medication Market Size by Country (2020-2025) & (US$ Million)
 Table 37. North America Atopic Dermatitis Medication Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Europe Atopic Dermatitis Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Europe Atopic Dermatitis Medication Market Size by Country (2020-2025) & (US$ Million)
 Table 40. Europe Atopic Dermatitis Medication Market Size by Country (2026-2031) & (US$ Million)
 Table 41. Asia-Pacific Atopic Dermatitis Medication Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia-Pacific Atopic Dermatitis Medication Market Size by Region (2020-2025) & (US$ Million)
 Table 43. Asia-Pacific Atopic Dermatitis Medication Market Size by Region (2026-2031) & (US$ Million)
 Table 44. Latin America Atopic Dermatitis Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Latin America Atopic Dermatitis Medication Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Atopic Dermatitis Medication Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Middle East & Africa Atopic Dermatitis Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Middle East & Africa Atopic Dermatitis Medication Market Size by Country (2020-2025) & (US$ Million)
 Table 49. Middle East & Africa Atopic Dermatitis Medication Market Size by Country (2026-2031) & (US$ Million)
 Table 50. Pfizer Company Details
 Table 51. Pfizer Business Overview
 Table 52. Pfizer Atopic Dermatitis Medication Product
 Table 53. Pfizer Revenue in Atopic Dermatitis Medication Business (2020-2025) & (US$ Million)
 Table 54. Pfizer Recent Development
 Table 55. Viatris Company Details
 Table 56. Viatris Business Overview
 Table 57. Viatris Atopic Dermatitis Medication Product
 Table 58. Viatris Revenue in Atopic Dermatitis Medication Business (2020-2025) & (US$ Million)
 Table 59. Viatris Recent Development
 Table 60. Allergan Company Details
 Table 61. Allergan Business Overview
 Table 62. Allergan Atopic Dermatitis Medication Product
 Table 63. Allergan Revenue in Atopic Dermatitis Medication Business (2020-2025) & (US$ Million)
 Table 64. Allergan Recent Development
 Table 65. Leo Pharma Company Details
 Table 66. Leo Pharma Business Overview
 Table 67. Leo Pharma Atopic Dermatitis Medication Product
 Table 68. Leo Pharma Revenue in Atopic Dermatitis Medication Business (2020-2025) & (US$ Million)
 Table 69. Leo Pharma Recent Development
 Table 70. Sanofi Company Details
 Table 71. Sanofi Business Overview
 Table 72. Sanofi Atopic Dermatitis Medication Product
 Table 73. Sanofi Revenue in Atopic Dermatitis Medication Business (2020-2025) & (US$ Million)
 Table 74. Sanofi Recent Development
 Table 75. Novartis Company Details
 Table 76. Novartis Business Overview
 Table 77. Novartis Atopic Dermatitis Medication Product
 Table 78. Novartis Revenue in Atopic Dermatitis Medication Business (2020-2025) & (US$ Million)
 Table 79. Novartis Recent Development
 Table 80. Bayer Company Details
 Table 81. Bayer Business Overview
 Table 82. Bayer Atopic Dermatitis Medication Product
 Table 83. Bayer Revenue in Atopic Dermatitis Medication Business (2020-2025) & (US$ Million)
 Table 84. Bayer Recent Development
 Table 85. Teva Pharmaceuticals Company Details
 Table 86. Teva Pharmaceuticals Business Overview
 Table 87. Teva Pharmaceuticals Atopic Dermatitis Medication Product
 Table 88. Teva Pharmaceuticals Revenue in Atopic Dermatitis Medication Business (2020-2025) & (US$ Million)
 Table 89. Teva Pharmaceuticals Recent Development
 Table 90. Bausch Health Company Details
 Table 91. Bausch Health Business Overview
 Table 92. Bausch Health Atopic Dermatitis Medication Product
 Table 93. Bausch Health Revenue in Atopic Dermatitis Medication Business (2020-2025) & (US$ Million)
 Table 94. Bausch Health Recent Development
 Table 95. Astellas Pharma Company Details
 Table 96. Astellas Pharma Business Overview
 Table 97. Astellas Pharma Atopic Dermatitis Medication Product
 Table 98. Astellas Pharma Revenue in Atopic Dermatitis Medication Business (2020-2025) & (US$ Million)
 Table 99. Astellas Pharma Recent Development
 Table 100. AstraZeneca Company Details
 Table 101. AstraZeneca Business Overview
 Table 102. AstraZeneca Atopic Dermatitis Medication Product
 Table 103. AstraZeneca Revenue in Atopic Dermatitis Medication Business (2020-2025) & (US$ Million)
 Table 104. AstraZeneca Recent Development
 Table 105. Metrochem API Company Details
 Table 106. Metrochem API Business Overview
 Table 107. Metrochem API Atopic Dermatitis Medication Product
 Table 108. Metrochem API Revenue in Atopic Dermatitis Medication Business (2020-2025) & (US$ Million)
 Table 109. Metrochem API Recent Development
 Table 110. Arcutis Biotherapeutics Company Details
 Table 111. Arcutis Biotherapeutics Business Overview
 Table 112. Arcutis Biotherapeutics Atopic Dermatitis Medication Product
 Table 113. Arcutis Biotherapeutics Revenue in Atopic Dermatitis Medication Business (2020-2025) & (US$ Million)
 Table 114. Arcutis Biotherapeutics Recent Development
 Table 115. Research Programs/Design for This Report
 Table 116. Key Data Information from Secondary Sources
 Table 117. Key Data Information from Primary Sources
 Table 118. Authors List of This Report


List of Figures
 Figure 1. Atopic Dermatitis Medication Picture
 Figure 2. Global Atopic Dermatitis Medication Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Atopic Dermatitis Medication Market Share by Type: 2024 VS 2031
 Figure 4. Corticosteroids Features
 Figure 5. PDE4 Inhibitors Features
 Figure 6. Biologics Features
 Figure 7. Skin Barrier Emollients Features
 Figure 8. CNI Immunosuppressants Features
 Figure 9. Others Features
 Figure 10. Global Atopic Dermatitis Medication Market Size by Application (2020-2031) & (US$ Million)
 Figure 11. Global Atopic Dermatitis Medication Market Share by Application: 2024 VS 2031
 Figure 12. Hospital Case Studies
 Figure 13. Clinic Case Studies
 Figure 14. Drugstore Case Studies
 Figure 15. Others Case Studies
 Figure 16. Atopic Dermatitis Medication Report Years Considered
 Figure 17. Global Atopic Dermatitis Medication Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Atopic Dermatitis Medication Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Atopic Dermatitis Medication Market Share by Region: 2024 VS 2031
 Figure 20. Global Atopic Dermatitis Medication Market Share by Players in 2024
 Figure 21. Global Top Atopic Dermatitis Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atopic Dermatitis Medication as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Atopic Dermatitis Medication Revenue in 2024
 Figure 23. North America Atopic Dermatitis Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Atopic Dermatitis Medication Market Share by Country (2020-2031)
 Figure 25. United States Atopic Dermatitis Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Atopic Dermatitis Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Atopic Dermatitis Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Atopic Dermatitis Medication Market Share by Country (2020-2031)
 Figure 29. Germany Atopic Dermatitis Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Atopic Dermatitis Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Atopic Dermatitis Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Atopic Dermatitis Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Atopic Dermatitis Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Atopic Dermatitis Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Atopic Dermatitis Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Atopic Dermatitis Medication Market Share by Region (2020-2031)
 Figure 37. China Atopic Dermatitis Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Atopic Dermatitis Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Atopic Dermatitis Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Atopic Dermatitis Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Atopic Dermatitis Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Atopic Dermatitis Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Atopic Dermatitis Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Atopic Dermatitis Medication Market Share by Country (2020-2031)
 Figure 45. Mexico Atopic Dermatitis Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Atopic Dermatitis Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Atopic Dermatitis Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Atopic Dermatitis Medication Market Share by Country (2020-2031)
 Figure 49. Turkey Atopic Dermatitis Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Atopic Dermatitis Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Atopic Dermatitis Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Pfizer Revenue Growth Rate in Atopic Dermatitis Medication Business (2020-2025)
 Figure 53. Viatris Revenue Growth Rate in Atopic Dermatitis Medication Business (2020-2025)
 Figure 54. Allergan Revenue Growth Rate in Atopic Dermatitis Medication Business (2020-2025)
 Figure 55. Leo Pharma Revenue Growth Rate in Atopic Dermatitis Medication Business (2020-2025)
 Figure 56. Sanofi Revenue Growth Rate in Atopic Dermatitis Medication Business (2020-2025)
 Figure 57. Novartis Revenue Growth Rate in Atopic Dermatitis Medication Business (2020-2025)
 Figure 58. Bayer Revenue Growth Rate in Atopic Dermatitis Medication Business (2020-2025)
 Figure 59. Teva Pharmaceuticals Revenue Growth Rate in Atopic Dermatitis Medication Business (2020-2025)
 Figure 60. Bausch Health Revenue Growth Rate in Atopic Dermatitis Medication Business (2020-2025)
 Figure 61. Astellas Pharma Revenue Growth Rate in Atopic Dermatitis Medication Business (2020-2025)
 Figure 62. AstraZeneca Revenue Growth Rate in Atopic Dermatitis Medication Business (2020-2025)
 Figure 63. Metrochem API Revenue Growth Rate in Atopic Dermatitis Medication Business (2020-2025)
 Figure 64. Arcutis Biotherapeutics Revenue Growth Rate in Atopic Dermatitis Medication Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Moderate to Severe Atopic Dermatitis Treatment Drugs Market Research Report 2024
Global Atopic Dermatitis Eczema Treatment Market Research Report 2025
Global Dermatitis Drugs Market Research Report 2024
Acne and Atopic Dermatitis Dermocosmetic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Feline Atopic Dermatitis Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dermatological Disorders Medications Market Research Report 2024
Medications for Canine Atopic Dermatitis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Canine Atopic Dermatitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prescription Dermatological Medications Market Research Report 2024
Global Dermatological Medicine Market Research Report 2024
Atopic Eczema Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Atopic Dermatitis Therapeutics Market Insights Forecast to 2030
Global Eczema Cream Market Research Report 2025
Global Dermatitis Herpetiformis Treatment Drugs Market Research Report 2024
Global ADHD Medication Market Research Report 2025
Global Allergy Medicine Market Research Report 2024
Global Derma Cosmetics Market Research Report 2025
Global Radiation Dermatitis Therapies Market Research Report 2024
Global Skin Allergy Treatment Market Insights Forecast to 2030
Global Radiation Dermatitis Cream Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions